DRKS00004670招募中不适用
Ambulant sleep stage analysis with simply measureable physiological parameters
Abteilung PneumologieUniversitätsklinikum Freiburg0 个研究点目标入组 60 人开始时间: 2013年1月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •minimum age of 18 years, maximum of 40 patients with sleep associated disease, minimum of 20 healthy subjects
排除标准
- •minimum age of 18 years, maximum of 40 patients with sleep associated disease, minimum of 20 healthy subjects
研究者
相似试验
已完成
1 期
A clinical study to Evaluate The Safety, Tolerability And Immunogenicity Of Three Formulations (15µg Without Adjuvant, 7.5µg With Adjuvant And 3.75µg With Adjuvant) Of Monovalent H1N1 Influenza A (2009) Virus Vaccine In Healthy Adults.CTRI/2010/091/000028Panacea Biotec Ltd72
进行中（未招募）
不适用
A phase IIa randomised, observer-blind, comparative study of the efficacy, tolerability and consumer acceptability of topical MedSpray™ TP 1 % versus Lamisil® Once 1 % in the treatment of tinea pedis - Tinea PedisMedDRA version: 9.1Level: LLTClassification code 10043873Term: Tinea pedistinea pedisEUCTR2008-002399-92-DEMedPharm Ltd.
已完成
2 期
Safety, Reactogenicity and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and InfantsCTRI/2011/12/002233ovartis Vaccine Institute for Global Health200
Unknown
不适用
A Study to assess the Safety and Immunogenicity of the MAlaria Vaccine, R1, With Matrix-M1 AdjuvantMalariaPACTR201610001813366Oxford University24
尚未招募
3 期
A randomised, controlled, observer-blinded phase III clinical trial to compare the effect of intravenous ferric carboxymaltose to placebo on exercise capacity and cardiac function in patients with chronic heart failure and iron deficiency - EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac function in patients with iron deficiencY and chronic Heart FailureHeart failureNL-OMON32525Vifor Pharma - Vifor International AG60